What you need to know
On October 15, the Boards of Trustees of Englewood Health and Hackensack Meridian Health signed a definitive agreement to merge.
Following regulatory approval of the merger, Hackensack Meridian Health has committed to a $400 million capital investment at Englewood Health. This investment would further position Englewood Health as a tertiary hub in northern New Jersey with a focus on cardiovascular care, neurosciences, oncology, robotic surgery, women’s health and neonatal intensive care, stroke care, thoracic surgery and an ambulatory care network throughout the region.
The signed deal follows an extensive review of clinical, regulatory, service, and financial issues by the two systems and will undergo regulatory review by the state’s Office of the Attorney General, New Jersey Department of Health, and the Federal Trade Commission before being finalized.